Combination of serum markers related to several mechanisms in Alzheimer's disease.
about
RXRA gene variations influence Alzheimer's disease risk and cholesterol metabolismCobalamin deficiency, hyperhomocysteinemia, and dementiaThe Role of Steroid Hormones in the Modulation of Neuroinflammation by Dietary InterventionsPossible modification of Alzheimer's disease by statins in midlife: interactions with genetic and non-genetic risk factorsIdentification of a new plasma biomarker of Alzheimer's disease using metabolomics technology.Inflammation and rate of cognitive change in high-functioning older adults.Total cholesterol and the risk of Parkinson's disease: a review for some new findings.Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview.Prediction of S-glutathionylated proteins progression in Alzheimer's transgenic mouse model using principle component analysisA novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's diseaseA validated LC-MS/MS assay for quantification of 24(S)-hydroxycholesterol in plasma and cerebrospinal fluid.Phenotypic profiles and functional genomics in Alzheimer's disease and in dementia with a vascular component.Genomic characterization of Alzheimer's disease and genotype-related phenotypic analysis of biological markers in dementia.Biomarkers of Alzheimer disease in plasmaRaman spectroscopy of blood serum for Alzheimer's disease diagnostics: specificity relative to other types of dementiaAssociation between History of Dental Amalgam Fillings and Risk of Parkinson's Disease: A Population-Based Retrospective Cohort Study in Taiwan.Homocysteine in relation to cognitive performance in pathological and non-pathological conditions.Lipid dysfunction and pathogenesis of multiple system atrophy.Brain cholesterol metabolism, oxysterols, and dementia.Atherosclerosis, biomarkers of atherosclerosis and Alzheimer's disease.C-reactive protein plays a marginal role in cognitive decline: a systematic review and meta-analysis.Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients.Age-related changes in nitric oxide activity, cyclic GMP, and TBARS levels in platelets and erythrocytes reflect the oxidative status in central nervous systemImpact of genetic variants of apolipoprotein E on lipid profile in patients with Parkinson's diseaseMild hypercholesterolemia, normal plasma triglycerides, and normal glucose levels across dementia staging in Alzheimer's disease: a clinical setting-based retrospective study.Peripheral biomarkers of oxidative stress in aging and Alzheimer's disease.Cytokines in Alzheimer's disease and vascular dementia.Biomarker identification for diagnosis of Alzheimer's disease.
P2860
Q24317054-5711DA8C-9BD1-484D-BE5C-A5505617C94FQ24609123-5F48D647-05DE-4214-8722-A8FAC546390EQ26766454-1FC07AC4-BEBF-437D-9D06-D57287DDDBB6Q30814231-57322778-9C69-4283-86FC-4B15032C55E2Q33452881-F9996609-4A80-4B01-B8AF-320A1DE5E335Q34187062-6302A922-9FC3-4A8D-93D7-91006DBEABC7Q34212035-1D8F9515-2B3D-466F-806F-90DD35BFEDEBQ34277859-9FF03F0C-3F3F-48E4-A0C6-0CBF77B76F71Q34466540-D55DAA06-75BD-4B96-A467-688897D63A04Q34795840-D445C6EF-9EB3-428B-ADD6-F905D3028EC2Q35642924-AB35E590-9CA1-45A4-8A38-899242058BADQ35841700-85EB8592-C6C2-4CA1-9F07-447B275FC246Q35976397-E459D10E-5769-46C1-83E1-321C64EA215AQ36045288-4C28172B-DA98-4510-B9DE-84333A3175B4Q36074237-9EEC4C3A-0A8F-4FEA-A941-5CF4AD56B7DFQ36209650-F517D8DC-3029-449A-8982-DB4DF5DC01ABQ36273343-0A9B156A-78B8-470F-B84D-EB09B0E325BFQ37580065-82AFCB38-7015-4F2F-A236-9639453FE84DQ38053046-05717832-3891-41AE-9522-13EE52F6B291Q38119019-7F982189-6060-404F-988F-D784CB71F29AQ38283212-50D9D173-D580-4AA0-AC95-153BE475E0C7Q38598430-56F8FDE2-54AD-48A9-8430-7817493A65DBQ41382771-D7A26CCF-D9CC-4562-8C4D-11CF2F88B68EQ42181761-970D5DA8-537D-4033-BD13-70AEB6A3AE3FQ46601342-22C372D0-16DD-4A03-89E3-9D6F260D61F5Q47105295-D1661D2F-91E3-4F9F-92AD-6FE448833BB0Q53396129-7E41CBA4-C5A2-4DC1-909F-417EDC0B75D6Q53480286-F52FD363-C3ED-4FFA-B3D2-D0526571A1FA
P2860
Combination of serum markers related to several mechanisms in Alzheimer's disease.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Combination of serum markers related to several mechanisms in Alzheimer's disease.
@en
Combination of serum markers related to several mechanisms in Alzheimer's disease.
@nl
type
label
Combination of serum markers related to several mechanisms in Alzheimer's disease.
@en
Combination of serum markers related to several mechanisms in Alzheimer's disease.
@nl
prefLabel
Combination of serum markers related to several mechanisms in Alzheimer's disease.
@en
Combination of serum markers related to several mechanisms in Alzheimer's disease.
@nl
P2093
P1476
Combination of serum markers related to several mechanisms in Alzheimer's disease.
@en
P2093
De Bruijn C
Delanghe J
Lütjohann D
Rieckmann P
Steinbusch HW
Teunissen CE
Verbeek MM
P304
P356
10.1016/S0197-4580(03)00005-8
P577
2003-11-01T00:00:00Z